Analysis

Lg Chem Ltd. (051910) Stock Analysis

Lg Chem Ltd. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to 051910.

website051910/analysis/051910

Lg Chem Ltd.

Lg Chem Ltd. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to 051910.

Stock profile

Ticker

051910

Asset type

Stock

Market cap

$16.38B

Sector

Process Industries

Industry

Chemicals: Specialty

Currency

KRW

Ticker listings

Lg Chem Ltd. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • 051910 primary listing
  • 051915

Latest Lg Chem Ltd. news

AVEO Oncology, an LG Chem company, Announces Two Poster Presentations at ASCO 2026 Annual Meeting

AVEO Oncology, an LG Chem company ("AVEO"), announced today that two abstracts were accepted for presentation at the upcoming American Society of Clinical Oncology (ASCO) 2026 a...

Frontier Medicines Announces Exclusive Licensing Agreement for FMC-220, a First-in-Class Covalent p53 Y220C Activator, with LG Chem, Ltd.

BOSTON & SAN FRANCISCO, April 01, 2026--Frontier Medicines Corporation, a clinical-stage precision medicines company unlocking the proteome to develop small molecule oncology an...

AVEO Oncology, an LG Chem company, Announces Completion of the First Interim Analysis in the Global Phase 3 FIERCE-HN Study

AVEO Oncology, an LG Chem company, (AVEO) announced today that the 20mg/kg dose of ficlatuzumab was selected for the combination arm of the Phase 3 registrational FIERCE-HN clin...

Palliser Capital Submits Proposal for LG Chem AGM to Address its Deep Discount and Governance Shortcomings

LONDON, February 09, 2026--Palliser Capital ("Palliser") today announced the submission of a shareholder proposal on 9 February 2026 for consideration at the upcoming Ordinary G...

AVEO Oncology, an LG Chem company, Announces First Patient Dosed in Front-Line AML Combination Study of Ficlatuzumab

AVEO Oncology, an LG Chem company, (AVEO) announced today that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzumab in combinatio...

Research sections

Valuation

Review valuation context for Lg Chem Ltd..

Future growth

Review future growth context for Lg Chem Ltd..

Past performance

Review past performance context for Lg Chem Ltd..

Financial health

Review financial health context for Lg Chem Ltd..

Dividend

Review dividend context for Lg Chem Ltd..

Management

Review management context for Lg Chem Ltd..

Ownership

Review ownership context for Lg Chem Ltd..

Other information

Review other information context for Lg Chem Ltd..

Community

Review community context for Lg Chem Ltd..